I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The safety and clinical effectiveness of rapid infusion wit..:
Bishton, Mark
;
Marshall, Scott
;
Harchowal, Jatinder
...
http://hdl.handle.net/10668/22028. , 2022
Link:
http://hdl.handle.net/10668/22028
RT Journal T1
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe
UL https://suche.suub.uni-bremen.de/peid=base-ftsspa:oai:www.repositoriosalud.es:10668_22028&Exemplar=1&LAN=DE A1 Bishton, Mark A1 Marshall, Scott A1 Harchowal, Jatinder A1 Salles, Gilles A1 Golfier, Camille A1 Tucci, Alessandra A1 Fernández, Alicia Rodriguez A1 Sanchez Blanco, Jose Javier A1 Bocchia, Monica A1 Kim, SooKyoung A1 Lee, Young Nam A1 Zinzani, Pier Luigi YR 2022 K1 biosimilar pharmaceuticals K1 chronic K1 infusion K1 intravenous K1 lymphocytic leukemia K1 lymphoma K1 non-Hodgkin K1 rituximab K1 Antibodies K1 Monoclonal K1 Murine-Derived K1 Drug-Related Side Effects and Adverse Reactions K1 Humans K1 Leukemia K1 Lymphocytic K1 B-Cell K1 Retrospective Studies K1 Treatment Outcome JF http://hdl.handle.net/10668/22028 LK http://hdl.handle.net/10668/22028 DO http://hdl.handle.net/10668/22028 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)